Cargando…
SARS-CoV-2 Omicron Variant in Patients With Chronic Myeloid Leukemia: A Retrospective Study
Background and aims Coronavirus disease 2019 (COVID-19) is caused by a virus known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Since the first pandemic wave, SARS-CoV-2 had developed significant changes and mutations that resulted in the emergence of different strains. Each stra...
Autores principales: | Ali, Elrazi A, Khamees, Ibrahim, Abu-Tineh, Mohammad, Qasim, Hana, Alshurafa, Awni, Ahmed, Khalid, Malkawi, Lujain, Yassin, Mohamed A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8989690/ https://www.ncbi.nlm.nih.gov/pubmed/35411288 http://dx.doi.org/10.7759/cureus.23863 |
Ejemplares similares
-
SARS-CoV-2 Omicron Variant in Patients With Chronic Lymphocytic Leukemia: Case Series
por: Khamees, Ibrahim, et al.
Publicado: (2022) -
A Case Series of SARS-CoV-2 Omicron Variant in Patients With Acute Leukemia
por: Ali, Elrazi A, et al.
Publicado: (2022) -
Tumor Lysis Syndrome in the Chronic Phase of Chronic Myeloid Leukemia Following COVID-19 Infection: A Case Report
por: Waseem Hajjar, Adnan Humam, et al.
Publicado: (2022) -
Radioactive Iodine-Induced Chronic Myeloid Leukemia in a Patient With Graves' Disease: A Case Report
por: Yasin, Ahmed K, et al.
Publicado: (2023) -
The Impact of Tyrosine Kinase Inhibitors on Fatherhood in Patients With Chronic Myeloid Leukemia: A Mixed-Method Study
por: Abu-Tineh, Mohammad, et al.
Publicado: (2023)